Experimental gene therapy can shield brain from toxic protein damage

A new study led by researchers at the University of California San Diego School of Medicine suggests that an experimental gene therapy could help protect the brain from the damage and cognitive decline linked to TDP-43-related proteinopathy, a type of neurodegeneration that is a major driver of frontotemporal dementia (FTD) and is also common in Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The study is published in Alzheimer's & Dementia.